Dr Amanda Dines is the Executive Director Royal Brisbane and Women's Hospital and Chair of Herston Medical Imaging Facility Executive Committee. Prior to this role she led the RBWH Cancer Care Service and she continues to be involved in the strategic development of cancer care services at Herston.
Dr Dines is a Monash University medical graduate, has Masters in Public Health from Harvard School of Public Health, and holds fellowships of the Royal Australasian Colleges of Medical Administrators and General Practice. She served in the Royal Australian Air Force as a Medical Officer for 24 years and is currently an Honorary Aide de Camp to the Governor General of Australia.
Associate Professor Markus Barth's main interests are the development of new techniques for MRI neuroimaging at high and ultra-high magnetic field strengths with a focus on brain functioning and neurological diseases. His achievements enable mapping of magnetic susceptibility in vivo in dementia and cancer, as well as ultra-fast and accurate functional imaging to better understand brain processes.
A/Prof Barth graduated from the Vienna University of Technology in Technical Physics in 1995 and was awarded his Doctorate in the Technical Sciences in 1999. From 2004 till 2014 he worked as a Senior Researcher at the Donders Institute for Brain, Cognition and Behaviour (Radboud University Nijmegen, NL) and at the Erwin L. Hahn Institute for Magnetic Resonance Imaging (University Essen-Duisburg, D). He then relocated to the University of Queensland to lead the ultra-high field human MR research program at the Centre for Advanced Imaging. He was awarded an ARC Future Fellowship in 2014.
Professor Michael Breakspear undertakes translational neuroimaging, with applications to mental health and neurological disorders, such as major depression, bipolar disorder, schizophrenia, dementia, epilepsy and Parkinson's Disease. He has published over 180 papers covering basic imaging methodology, computational modelling and clinical application.
Professor Galloway is Director of Imaging Technology for the Translational Research Institute (TRI) and Chief Executive officer for the National Imaging Facility (NIF). In both roles he is passionate about collaboration, and using cutting edge technology to solve real-world problems.
His research interests include the use of in vivo Magnetic Resonance to identify disease, testing the efficacy of new therapies, and in pushing the boundaries of the technology into novel applications for the use of Magnetic Resonance in physiological studies and material sciences.
Professor Galloway's role in all projects is characterised by his multidisciplinary background, which ensures that he is able to draw together these apparently disparate threads.
Professor Frank Gannon is the Director and CEO of the QIMR Berghofer Medical Research Institute. He joined QIMR Berghofer in January 2011, having been Director General and board member of Science Foundation Ireland (SFI) since 2007.
He obtained his PhD from the University of Leicester, England in 1973 and worked subsequently in the USA, France, Ireland and Germany where he was Executive Director of the European Molecular Biology Organisation (EMBO) from 1994-2007.
His major research interest is the regulation of gene expression by the oestrogen receptor, which plays a major role in breast and endometrial cancer.
He is a founding Board Member of the Herston Imaging Research Facility (HIRF).
Adjunct Professor Liz Kenny is the Medical Director of Queensland's Central Integrated Regional Cancer Service. She is also Medical Director for the Herston Imaging Research Facility and a Senior Radiation Oncologist at the RBWH. Her main areas of specialty interest are Head and Neck Cancer and Breast Cancer.
Liz is committed to research that is outcome focussed, aiming to both improve cure and reduce the morbidity of treatment and has brought together a number of clinical and research teams on the Herston campus with this aim. Liz is also a member of the Cardiovascular and Interventional Radiological Society of Europe, providing advice regarding evidence for interventional procedures and the development of a quality assurance framework.
Liz has been awarded several Honorary Memberships and Honorary Fellowships in both Europe and North America and most recently was appointed as an officer of the Order of Australia.
Dr Phillip Law is a clinical radiologist and nuclear medicine specialist on the senior medical staff of the Princess Alexandra Hospital, and senior lecturer in the School of Medicine at the University of Queensland. His subspecialty interests include imaging in oncology and cardiology with particular emphasis on the clinical applications of molecular imaging in the provision of functional data to complement high-resolution anatomical data across multiple imaging modalities (SPECT/CT, PET/CT, PET/MR).
He has research interests in SPECT and PET quantitative methodology, novel radiotracers and their clinical applications in the fields of oncology and cardiology, and the use of imaging parameters as an aid to prognostication and treatment decision making in clinical oncology.
Professor Carolyn Mountford is CEO and Director of Research at the Translational Research Institute (TRI) and has a long interaction with the diagnostic imaging industry. Her team has been a worldwide development site for Siemens since 1999.
She is a co-inventor of the diagnostic protocol to monitor women at high risk for breast cancer identifying metabolic deregulations in their breast tissue that precede tumour growth. The same technology is shown to identify changes to the brain associated with learning, memory, Post Traumatic Stress Disorder (PTSD) and injury from blast and impact. Her team are under contract to the USA and Australian military to develop this approach to improve the health of soldiers.
Prior appointments include Professor of Radiology, Harvard Medical School and Director of the Centre for Clinical Spectroscopy at the Brigham and Women's Hospital.
Professor David Reutens is the inaugural director of the Centre for Advanced Imaging (CAI), Foundation Professor of Experimental Neurology at The University of Queensland and Director of the ARC Centre for Innovation in Biomedical Imaging Technology. He graduated in Medicine from the University of Western Australia in 1984 and trained in neurology, obtaining his Fellowship of the Royal Australasian College of Physicians in 1991. After completing his Doctor of Medicine at The University of Melbourne in 1993, he undertook a post-doctoral fellowship at the McConnell Brain Imaging Centre of the Montreal Neurological Institute. Previous academic appointments have been as Assistant Professor, McGill University, Associate Professor, The University of Melbourne and Professor of Neuroscience, Monash University.
He is also a Senior Staff Specialist in Neurology at the Royal Brisbane and Women's Hospital and was previously Director of Neurology at Monash Health. Professor Reutens's research involves the combination of preclinical and human imaging techniques to study functions such as learning and memory in the healthy brain, the mechanisms behind diseases such as epilepsy, dementia and stroke and how the brain responds to overcome injury. His research also involves the development of new imaging techniques and agents for example to characterise tissue structure, molecular and metabolic characteristics and function.
Dr Salvado graduated with a MSEE in France. After working several years for a commercial company he obtained a PhD in Biomedical Engineering from Case Western Reserve University, Cleveland, USA. He has been investigating vascular imaging using MRI before moving to Australia as a research scientist for the CSIRO. He is now leading the CSIRO Biomedical Informatics Group, based at the Australian eHealth Research Centre. His Group develops innovative technologies to analyse medical data, including MRI, PET, biomarkers, and genetics.
Dr Salvado has several adjunct positions with Australian universities, he is a regular assessor of scientific grants, a reviewer of international journals, he is regularly involved in reviewing and organising international conferences, and is honorary Professor at the University of Queensland.
Associate Professor Paul Thomas is Director of the Herston Imaging Research Facility and Assistant Director of Specialised PET Services Queensland at the Royal Brisbane and Women's Hospital. Paul is the Vice President of the Australasian Association of Nuclear Medicine Specialists.
Paul has a variety of research interests in PET/CT and PET/MR including PSMA PET/CT and PET/MR in prostate cancer staging and radiotherapy planning, PSMA PET in renal cell carcinoma, hypoxia and FDOPA imaging of glioma, chemokine imaging and risk stratification in malignancy, and technical projects focussing on both motion correction and kinetic analysis to improve the detection of metastatic disease.
Professor Ross Young was appointed Executive Dean, Faculty of Health QUT in January 2013 following seven years as Executive Director, Institute of Health and Biomedical Innovation (IHBI), QUT.
Professor Young is a Clinical Psychologist and his research interests lie in the integration of psychological and biological risk factors in mental illness. His research includes work in substance misuse, schizophrenia, anxiety disorders, mood disorders and more broadly in behavioural medicine. This includes work in pharmacogenomics and personalised medicine. Professor Young has over 250 published book chapters and papers in genetic, medical, psychiatric and psychological journals. Professor Young leads a Faculty of Health at QUT focussed on harnessing technology in the provision of effective and efficient care and encourages a transdisciplinary approach to problem solving.
Professor de Zubicaray's research program focusses on investigating the neural and cognitive mechanisms responsible for language processing, how these mechanisms are affected by brain tumours and stroke, how our genome helps us speak, and how language recovery can be facilitated by various treatments.
His research areas include Neurobiology of language and memory; Cognitive neuroscience; Neuroimaging; Psycholinguistics.
Imaging@Brisbane 2018 is hosted by seven major research centres involved across three significant multi-modal medical imaging facilities located in the state's capital. This unique multi-disciplinary collaboration forges the foundation for a conference that will attract world-wide attendance and showcase all that medical imaging innovation has to offer health care now, and into the future.©Imaging@Brisbane 2018